...
首页> 外文期刊>Transplantation Proceedings >Comparison of 1-year patient and graft survival rates between preemptive and dialysed simultaneous pancreas and kidney transplant recipients.
【24h】

Comparison of 1-year patient and graft survival rates between preemptive and dialysed simultaneous pancreas and kidney transplant recipients.

机译:先发性和透析性同时胰腺和肾脏移植接受者的1年患者和移植物存活率的比较。

获取原文
获取原文并翻译 | 示例

摘要

It is well known that the main decrease in graft and recipient survival rates is observed during the first 12 months after transplantation. Improving results during this period seems to be crucial for the late outcome. The aim of this study was to compare 1-year survival rates of dialyzed and preemptive pancreas and renal graft recipients and their graft function. From November 1999 to January 2005, 42 whole simultaneous pancreas and kidney transplantations (spktx) were stratified into group I (n = 13): recipients who received a preemptive pancreas and kidney transplant versus group II (n = 29): previously dialyzed spktx recipients. The mean time of dialysis for group II was 39 +/- 16.5 months. We assessed 1-year cumulative survival rates for recipients and grafts for each group. The 1-year cumulative survival rate for preemptive graft recipients was significantly higher than that for dialyzed patients before spktx (100% vs 69%; P = .05). For groups I and II 1-year cumulative graft survival rates for kidney grafts were 100% and 89%, respectively, and for pancreatic grafts 84% and 65.5%, respectively. There was a significant improvement in the 1-year survival rate of preemptive spktx recipients compared with patients dialyzed before spktx. However, 1-year pancreas and kidney graft function did not differ significantly between the groups.
机译:众所周知,在移植后的前12个月内观察到移植物和受体存活率的主要下降。在此期间改善结果似乎对于后期结果至关重要。这项研究的目的是比较透析和先发胰腺和肾移植受者的1年生存率及其移植功能。从1999年11月至2005年1月,将42例同时进行的胰腺和肾脏同时移植(spktx)分为第一组(n = 13):接受先发性胰腺和肾脏移植的接受者与第二组(n = 29):先前透析过的spktx接受者。第二组的平均透析时间为39 +/- 16.5个月。我们评估了每组接受者和移植物的1年累积生存率。抢先移植接受者的1年累积生存率显着高于spktx之前透析的患者(100%比69%; P = 0.05)。对于I和II组,肾移植物的1年累积移植存活率分别为100%和89%,而胰腺移植物的1年累积移植存活率分别为84%和65.5%。优先于spktx接受者的1年生存率与在spktx之前透析的患者相比有显着改善。然而,两组之间的1年胰腺和肾移植功能没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号